Obesity Research
Clinical Trial

Obesity Research Clinical Trial in Denver

We are pleased to announce the obesity research clinical trial as the next in our series. We are excited to share this opportunity with eligible patients at GI of the Rockies.

We are currently enrolling people with obesity and diabetes. Consider enrolling in the study if you are curious about this clinical trial.

We will continue offering our series of clinical trials in Denver with our trusted partner, Advanced Research Institute (ARI).

ARI staff are available to answer your questions about this obesity research trial and help determine if you qualify for the study. Qualified participants may potentially gain access to GLP-1/GIP dual agonist medications.

In previous research studies, GLP-1 receptor agonists have shown significant weightloss outcomes, reported in 2024, in the journal Obesity.

The question is: Could this type of therapy potentially work for you?

Graphic depicting info about a clinical trial for people with diabetes and obesity

Enroll today

Want More Information About Obesity Research Clinical Trials in Denver?

If you’ve tried different weight loss methods or medications and felt unsatisfied with the results – we encourage you to request more information about this obesity research study. Many people report a lack of satiety when trying to shed pounds. Learn how GLP-1/GIP dual agonist therapies may help some people with satiety levels and weight loss.

Find out how GLP-1/GIP dual agonist medications work with major organs — like the brain, pancreas and stomach. Curious about how or why dual agonist medications may have potential to help some people who are overweight and obese? So are we. That’s why we are excited about launching this obesity research clinical trial.

According to growing body of evidence-based research, some overweight people may respond better to therapies with both GLP 1 and GIP components – as these combined peptides target appetite hormones and other metabolic factors. See the graphic illustration.

Sources: JAMA Internal Medicine, 2024 & Washington University, St. Louis, 2025

Curious about the pancreas? Check out our page that explores this important organ and how it helps the liver, small intestine and gallbladder.

Valuable research opportunities like this continue to help more people gain access to quality healthcare — while also helping advance medical research.

Want to learn more about obesity research clinical trials in Denver? Fill out this form today. Enroll today.

Or reach out by phone at 303-353-2660. You will be connected to an Advanced Research Institute coordinator.

Graphic display of GLP1 medication and its effect on major organs, like brain, pancreas, stomach — Glucagon-like peptide-1. GLP-1 from blood vessel to pancreas, brain and stomach looks at the relationship between satiety, appetite hormones, insulin, glucagon, gastric motility, and emptying.

Click here to learn more about ARI.